Table 2 Relationship between sleep subscales and predictive factors
95% CI | ||||
|---|---|---|---|---|
Factor | β coefficient | Lower | Upper | p-value |
Sleep disturbance subscale* | ||||
Sleep loss/disruption due to illness | ||||
Yes | 48 | -7.83 | 105.01 | 0.092 |
No (reference) | 0 | 0 | 0 | |
# of chronic diseases | -30.33 | -46.78 | -13.88 | 0.0003 |
Pain | ||||
Yes (reference) | 0 | 0 | 0 | |
No | -135 | -218.31 | -51.71 | 0.0015 |
Bedtime sedative | <0.0001 | |||
None | 57.33 | -13.48 | 128.15 | 0.11 |
Benzodiazepines | 60.75 | -12.87 | 134.4 | 0.11 |
Tricyclic antidepressants | 250.73 | 189.25 | 312.22 | <0.0001 |
Loxapine | 16.24 | -94.09 | 126.57 | 0.77 |
Zopiclone (reference) | 0 | 0 | 0 | |
# of chronic disease without pain | 27.16 | 3.51 | 50.81 | 0.024 |
# of chronic disease with pain (reference) | 0 | 0 | 0 | |
Sleep supplementation subscale | ||||
Age (by year) | -1.88 | -3.07 | -0.7 | 0.0018 |
Bedtime sedative | <0.0001 | |||
None | -18.12 | -54.66 | 18.41 | 0.33 |
Benzodiazepines | -39.55 | -83.68 | 4.58 | 0.079 |
Tricyclic antidepressants | -57.82 | -92.51 | -23.13 | 0.0011 |
Loxapine | 2.92 | -112.48 | 118.33 | 0.96 |
Zopiclone (reference) | 0 | 0 | 0 | |
Sleep effectiveness subscale | ||||
Day of hospitalization | -2.65 | -4.88 | -0.43 | 0.02 |
Bedtime sedative | 0.0031 | |||
None | 33.8 | 16.24 | 51.36 | 0.0002 |
Benzodiazepines | 32.82 | 13.87 | 51.78 | 0.007 |
Tricyclic antidepressants | 29.74 | 13.47 | 46.02 | 0.0003 |
Loxapine | 20.18 | 4.35 | 36.01 | 0.013 |
Zopiclone (reference) | 0 | 0 | 0 | |
Pain | ||||
Yes (reference) | 0 | 0 | 0 | |
No | -15.76 | -30.04 | -1.47 | 0.031 |